Literature DB >> 492283

Acute renal failure from ticrynafen.

W M Bennett, P E Van Zee, R Hutchings.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 492283     DOI: 10.1056/NEJM197911223012112

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Acute reversible renal impairment produced by a uricosuric diuretic.

Authors:  F A Hubbell; M A Weber; B B Megaffin; D D Brewer
Journal:  West J Med       Date:  1980-11

2.  Sulphinpyrazone-induced acute renal failure.

Authors:  D S Durham; L S Ibels
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-21

3.  Effect of tienilic acid and amiloride in healthy volunteers and in hypertensives with normal renal function.

Authors:  J B Myers; A Gillies; S Waga; T O Morgan
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

4.  The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics.

Authors:  M W Johnson; W E Mitch
Journal:  Drugs       Date:  1981-03       Impact factor: 9.546

5.  Acute interstitial nephritis in a patient taking tienilic acid.

Authors:  R G Walker; J A Whitworth; P Kincaid-Smith
Journal:  Br Med J       Date:  1980-05-17

6.  Ticrynafen and hydrochlorothiazide. A comparison in hypertensive patients with renal impairment.

Authors:  B T Emmerson; P J Renshaw; P J Ravenscroft; I Denham; S Schey
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 7.  Effects of non-narcotic analgesics on the kidney.

Authors:  P Kincaid-Smith
Journal:  Drugs       Date:  1986       Impact factor: 9.546

8.  Tienilic acid: a single treatment for hyperuricaemia and hypertension?

Authors:  T Gibson; V A Rodgers; C F Potter; H A Simmonds
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

9.  Multicentre controlled trial of tienilic acid in hyperuricaemic, hypertensive subjects, with intensive monitoring of liver function.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.